A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 48, Issue 5, 2009, Pages 519-532

  Wagner, Karen Dineen ^a,h   Redden, Laura ^b   Kowatch, Robert A ^c   Wilens, Timothy E ^d   Segal, Scott ^e   Chang, Kiki ^f   Wozniak, Patricia ^g   Vigna, Namita V ^b   Abi Saab, Walid ^b   Saltarelli, Mario ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Segal Institute for Clinical Research   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Advanced Clinical Research Services

^h University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Bipolar disorder; Divalproex ER; Treatment

Indexed keywords

AMMONIA; LORAZEPAM; PLACEBO; VALPROATE SEMISODIUM; ZOLPIDEM TARTRATE; TRANQUILIZER; VALPROIC ACID;

ABDOMINAL PAIN; ADOLESCENT; AGITATED DEPRESSION; AMMONIA BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTRITIS; HEADACHE; HUMAN; INCIDENCE; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANIA; MIXED MANIA AND DEPRESSION; MONOTHERAPY; NAUSEA; NOSE CONGESTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SEDATION; SIDE EFFECT; SOMNOLENCE; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT GAIN; YOUNG MANIA RATING SCALE; ANALYSIS OF VARIANCE; BLOOD; DELAYED RELEASE FORMULATION; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; REFERENCE VALUE;

ADOLESCENT; AMMONIA; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REFERENCE VALUES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 67650296336     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e31819c55ec     Document Type: Article

References (54)

1. Geller B, Tillman R, Craney JL, Bolhofner K. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry. 2004;61:459-467.
2. Birmaher B, Axelson D, Strober M et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:175-183.
3. Goldstein TR, Birmaher B, Axelson D et al. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. 2005;7:525-535.
4. Leverich GS, Post RM, Keck PE Jr et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr. 2007;150:485-490.
5. Kowatch RA, Suppes T, Carmody TJ et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713-720.
6. Wagner KD, Weller EB, Carlson GA et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002;41:1224-1230.
7. Henry CA, Zamvil LS, Lam C, Rosenquist KJ, Ghaemi SN. Long-term outcome with divalproex in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2003;13:523-529.
8. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord. 2004;82(Suppl 1):S103YS111.
9. DelBello MP, Kowatch RA, Adler CM, Stanford KE et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2006;45: 305-313.
10. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision. Washington: American Psychiatric Association; 2000.
11. Geller B, Warner K, Williams M, Zimerman B. Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord. 1998;51:93-100.
12. Geller B, Zimerman B, Williams M et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) Mania and Rapid Cycling Sections. J Am Acad Child Adolesc Psychiatry. 2001;40:450-455.
13. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435.
14. Fristad MA, Weller EB, Weller RA. "The Mania Rating Scale: can it be used in 18 children?" J Am Acad Child Adolesc Psychiatry. 1992;31: 252-257.
15. In: Guy W, ed. Clinical Global Impressions in Early Clinical Drug Evaluation Unit 20. Assessment Manual for Psychopharmacology, U.S. National Institute of Mental Health. Rockville: DHEW Publication No. [ADM]; 1976:76-338.
16. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R. Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Psychiatry. 1984;23: 191-197.
17. Poznanski EO, Mokros HB. Children's Depression Rating Scale Revised. Los Angeles: Western Psychological Services; 1999.
18. Brannan AM, Heflinger CA, Bickman L. "The Caregiver Strain Questionnaire: measuring the impact on the family of living with a child with serious emotional disturbance". J Emot Behav Disord. 1997;5:212-222.
19. Shaffer D, Gould MS, Brasic J et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40:1228-1231.
20. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale IV: 33. Checklists, Norms, and Clinical Interpretations. New York: The Guilford Press; 1998.
21. Medical Dictionary for Regulatory Activities (MedDRA®) Version 9.0, MedDRA MSSO, c/o of TRW, VAR1/8A/MSSO, 12011 Sunset Hills Road, Reston, VA 20190-3285, USA.
22. Bowden CL, Swann AC, Calabrese JR et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006;67:1501-1510.
23. Gerstner T, Teich M, Bell N et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006;47:1136-1143.
24. Koenig S, Gerstner T, Keller A et al. High incidence of valproate-induced coagulation disorders in children receiving valproic acid: a prospective study. Blood Coagul Fibrinolysis. 2008;19:375-382.
25. Attilakos A, Katsarou E, Voudris K, Garoufi A. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2007;48: 205-206.
26. Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000;22:62-65.
27. Depakote ER [package insert]. North Chicago: Abbott Laboratories; 2008.
28. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry. 2007;46:687-700. Review.
29. Maranda B, Cousineau J, Allard P, Lambert M. False positives in plasma ammonia measurement and their clinical impact in a pediatric population. Clin Biochem. 2007;40:531-535.
30. Urea Cycle Disorders Conference Group. Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr. 2001;138:S1YS5.
31. Wyllie E, Wyllie R, Rothner A et al. Valproate-induced hyperammone-mia in asymptomatic children. Cleve Clin Q. 1983;50:275-277.
32. Apostol G, Cady R, Laforet G et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache. 2008;48:1012-1025.
33. Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol. 2004;24:322-334.
34. United States Food and Drug Administration, Center for Drug Evaluation and Research. Statistical Review and Evaluation. Antiepileptic Drugs and Suicidality. http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01- FDA.pdf. Accessed July 14, 2008.
35. United States Food and Drug Administration, Center for Drug Evaluation and Research. Information for Healthcare Professionals: Suicidality and Antiepileptic Drugs. 1/31/2008. http://www.fda.gov/cder/drug/InfoSheets/HCP/ antiepilepticsHCP.htm. Accessed February 5, 2008.
36. DelBello MP, Findling RL, Kushner S et al. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:539-547.
37. Wagner KD, Kowatch RA, Emslie GJ et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006;163: 1179-1186.
38. Erratum in: Am J Psychiatry. 2006;163:1843.
39. Tohen M, Kryzhanovskaya L, Carlson G et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry. 2007;164:1547-1556.
40. Pandina G, DelBello M, Kushner S et al. Risperidone for the Treatment of Acute Mania in Bipolar Youth. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2007; Boston, MA.
41. DelBello M, Findling R, Earley W et al. Efficacy of Quetiapine in Children and Adolescents With Bipolar Mania: A 3-Week, Double-Blind, Randomized, Placebo-Controlled Trial. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2007; Boston, MA.
42. Chang K, Nyllas M, Aurang C et al. Efficacy of Aripiprazole in Children (10-17 Year Old) With Mania. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2007; Boston, MA.
43. Bowden C, Brugger A, Swann A et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The depakote mania study group. JAMA. 1994;271:918-924.
44. Bowden C, Swann A, Calabrese J et al. A randomized placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006;67:1501-1510.
45. Pope H, McElroy S, Keck P et al. Valproate in the treatment of acute mania. Arch Gen Psychiatry. 1991;48:62-68.
46. Dutta S, Zhang Y, Conway J et al. Divalproex-ER pharmacoki-netics in older children and adolescents. Pediatr Neurol. 2004;30: 330-337.
47. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164:582-590.
48. Coletti DJ, Leigh E, Gallelli KA, Kafantaris V. Patterns of adherence to treatment in adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2005;15:913-917.
49. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:1216-1223.
50. Findling RL, McNamara NK, Gracious BL et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry. 2003;42:895-901.
51. Kowatch R, Sethuraman J, Hume J et al. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry. 2003;53:978-984.
52. Schatzberg AF. Employing pharmacologic treatment of bipolar disorder to greatest effect. J Clin Psychiatry. 2004;65(suppl 15):15-20.
53. Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry. 2003;64(suppl 5):18-24.
54. Hirschfeld M, Bowden Cl, Gitlin MJ et al, and the Work Group for the Treatment of Patients with Bipolar Disorder. APA. 2002. http://www. psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=Bipolar2ePG-05-15-06.